Champions Oncology Inc (CSBR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.88
• Market Cap: $83.04M
• P/E Ratio: 35.18
• EPS: $0.17
• 52-Week High: $11.06
• 52-Week Low: $5.59

About Champions Oncology Inc

Champions Oncology, Inc. (CSBR) is a leading innovator in the field of cancer therapy, headquartered in Hackensack, New Jersey. The company specializes in developing advanced technology solutions that enhance the efficacy and personalization of oncology treatments. By leveraging proprietary tumor models and sophisticated data analytics, Champions Oncology enables pharmaceutical partners and researchers to create tailored drug development strategies, significantly improving patient outcomes. A...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Champions Oncology Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CSBR pay dividends?

Champions Oncology Inc (CSBR) does not currently pay a regular dividend.

What is CSBR's P/E ratio?

Champions Oncology Inc has a price-to-earnings (P/E) ratio of 35.18.

What is CSBR's market cap?

Champions Oncology Inc (CSBR) has a market capitalization of $83.04M with a current stock price of $5.88.